News & Events

Instinctif Partners Congratulates the Finalists of the 14th Annual Scrip Awards

Instinctif Partners Congratulates the Finalists of the 14th Annual Scrip Awards

London, UK, 28 September 2018 - Instinctif Partners, the business communications consultancy, congratulates all of the shortlisted companies of the Scrip Awards 2018. Now in its 14th year, the Scrip Awards acknowledge the highest achievers across the pharmaceutical and biotech industries, recognising both corporate and individual achievement.

Congratulations goes especially to Instinctif Partners Life Sciences’ clients F-star, Roche, Crescendo, Abcam and IQVIA who have been shortlisted across the 17 award categories. These are:


  • Executive of the Year – For Large & Medium Cap Companies - Alan Hirzel, CEO

Crescendo Biologics

  • Financing Deal of the Year – Private – for Crescendo’s $70m Series B financing


  • Best Partnership Alliance – with Denali Therapeutics to develop a multi-specific platform for delivery of medicines across the blood-brain barrier
  • Licensing Deal of the Year – Sponsored by Worldwide Clinical Trials - F-star (through F-star Delta) and Merck KGaA for five bispecific antibodies in immuno-oncology
  • Business Development Team of the Year
  • WuXi AppTec’s Biotech Company of the Year Award


  • Best Contract Research Organization – Full-Service Providers
  • Best Technological Development in Clinical Trials - Clinical Sponsor-focused – for IQVIA’s Mobile SVR application
  • Community Partnership of the Year Award – Sponsored by Medidata Solutions - IQVIA India’s Race for 7 with the Organization for Rare Diseases India
  • Best Use of Real-World Evidence - IQVIA/Bristol-Myers Squibb’s I-O Optimise collaboration in patients with a thoracic malignancy


  • Best Partnership Alliance – with Ionis Pharmaceuticals to develop antisense drugs for Huntington's disease
  • Syneos Health's Best New Drug Award – for Roche’s Hemlibra (emicizumab)

The Scrip Awards recognise success across a range of industry activities, including novel deals, new drug launches and technological breakthroughs in clinical trials.

The winners of the Scrip Awards will be announced at a prestigious dinner and ceremony taking place on 28 November at the Hilton on Park Lane, London. The full list of award categories and winners, as selected by a panel of 17 highly respected judges, can be found here.

Commenting on the announcement of the finalists, Sue Charles, Managing Partner of Instinctif Partners Life Sciences’ practice said:

“The eagerly anticipated Scrip Awards reflect significant achievements throughout our sector and the quality of nominations are always very high. This year’s shortlist reflects a strong year of innovation across the board and it is great to see the accomplishments of our clients recognised at such a distinguished industry event.”

About Instinctif Partners Life Sciences

Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.

back to news